Pancreatic Cancer Research

ResearcherXijing HospitalNo recent work listed

Haimin Li

Matched on ORCID iD 0000-0003-0276-615X; OpenAlex author ID A5065118117.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
5 (first author 1, last author 3)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Labs led
1
Collaborators
2
Papers, trials and grants by year

2015: 1 paper · 2016: 2 papers · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper

Papers 5

  1. LINC00671 suppresses cell proliferation and metastasis in pancreatic cancer by inhibiting AKT and ERK signaling pathway. Last author DOI 10.1038/s41417-020-00213-4↗
  2. Circular RNA circRHOT1 is upregulated and promotes cell proliferation and invasion in pancreatic cancer. Co-author DOI 10.2217/epi-2018-0051↗
  3. Downregulation of lncRNA-ATB correlates with clinical progression and unfavorable prognosis in pancreatic cancer. Last author DOI 10.1007/s13277-015-4252-y↗
  4. Circular RNA Expression Profile of Pancreatic Ductal Adenocarcinoma Revealed by Microarray. First author DOI 10.1159/000453186↗
  5. Microarray expression profile of circular RNAs in human pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.gdata.2015.07.017↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Shibin Qu · 5 shared papers, 2015–2021
  2. Zhengcai Liu · 3 shared papers, 2016–2021

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.